Precision Beyond Limits

​

​​​A healthy world beyond the limits of disease and disability. CELLTIUM is shaping that future.

 

CELLTIUM harnesses Precision Neurotechnology to develop disease-modifying therapies for intractable neurological disorders, with a primary focus on Charcot–Marie–Tooth disease (CMT). Our mission is clear: to restore nerve function so that patients and families can reclaim their daily lives and envision a new future.

​

​United by a shared passion for innovation, our team integrates neuroscience, drug development, and bioengineering. Powered by our proprietary PRECISION™ HCS platform, we strive to create First-in-Class therapeutics that redefine the treatment landscape for rare neurological diseases.

 

​Together with patients, families, investors, and partners, CELLTIUM is building a new global standard of care for people living with neurological disorders.

 

​CELLTIUM​